Literature DB >> 15882878

VEGF-mediated survivin expression in neuroblastoma cells.

Elizabeth A Beierle1, Abhilasha Nagaram, Wei Dai, Meera Iyengar, Mike K Chen.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) up-regulates a number of cellular survival signals in endothelial cells. We hypothesize that VEGF will up-regulate survivin, a member of the IAP family of anti-apoptotic proteins, via the PI3K/Akt cell signaling pathway in human neuroblastoma cells.
MATERIALS AND METHODS: IMR-32 human neuroblastoma cells are cultured with VEGF at varying times and in escalating doses. A specific inhibitor of PI3-kinase, LY294002, is used to block Akt phosphorylation. Immunoblot is used to measure protein expression, and Hoechst staining is used to detect apoptosis.
RESULTS: Stimulation of IMR-32 neuroblastoma cells with VEGF results in an increase in survivin protein expression in both a dose- and a time-dependent fashion. Akt phosphorylation is also increased after stimulation with exogenous VEGF. Blockade of Akt phosphorylation with LY294002 abrogates the effects of VEGF upon survivin and phosphorylated Akt protein expression.
CONCLUSIONS: VEGF has been shown to up-regulate a number of survival signals in endothelial cells. We have found that exposure of human neuroblastoma cells to exogenous VEGF results in an increased expression of survivin protein and phosphorylated Akt, and inhibition of PI3-kinase abrogates those effects. It appears that VEGF is important for promotion of neuroblastoma cellular survival through the up-regulation of survival proteins, and not only through its angiogenic properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882878     DOI: 10.1016/j.jss.2005.03.009

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  24 in total

1.  Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis.

Authors:  Ping Chen; Jiang Zhu; Ding-Yi Liu; Hui-Yan Li; Nie Xu; Mei Hou
Journal:  Med Oncol       Date:  2013-12-15       Impact factor: 3.064

2.  Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancer.

Authors:  Meng Wang; Bao-Gang Liu; Zhao-Yang Yang; Xuan Hong; Gong-Yan Chen
Journal:  Exp Ther Med       Date:  2012-03-12       Impact factor: 2.447

Review 3.  The connections between neural crest development and neuroblastoma.

Authors:  Manrong Jiang; Jennifer Stanke; Jill M Lahti
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

4.  Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis.

Authors:  Petra Obexer; Judith Hagenbuchner; Thomas Unterkircher; Nora Sachsenmaier; Christoph Seifarth; Günther Böck; Verena Porto; Kathrin Geiger; Michael Ausserlechner
Journal:  Mol Biol Cell       Date:  2009-02-11       Impact factor: 4.138

5.  Hyperglycemia attenuates angiogenic capability of survivin in endothelial cells.

Authors:  Qinhui Song; Xiaojin An; Dongmei Li; Neel R Sodha; Munir Boodhwani; Ye Tian; Frank W Sellke; Jian Li
Journal:  Microvasc Res       Date:  2009-08-27       Impact factor: 3.514

Review 6.  More than the genes, the tumor microenvironment in neuroblastoma.

Authors:  Lucia Borriello; Robert C Seeger; Shahab Asgharzadeh; Yves A DeClerck
Journal:  Cancer Lett       Date:  2015-11-17       Impact factor: 8.679

7.  Significance of survivin, caspase-3, and VEGF expression in thyroid carcinoma.

Authors:  Hai-Yan Zhang; Xin Meng; Zhen-Xian Du; Chang-Qing Fang; Guo-Liang Liu; Hua-Qin Wang; Wei-Wei Deng
Journal:  Clin Exp Med       Date:  2009-02-10       Impact factor: 3.984

8.  Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy.

Authors:  Lisa D Volk; Michael J Flister; Christopher M Bivens; Alan Stutzman; Neil Desai; Vuong Trieu; Sophia Ran
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

9.  Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma.

Authors:  Patrick Terheyden; Maja Ann Hofmann; M Weininger; Eva-B Bröcker; Jürgen C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-22       Impact factor: 4.553

10.  Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.

Authors:  Samson Mathews Samuel; Yuzo Akita; Debayon Paul; Mahesh Thirunavukkarasu; Lijun Zhan; Perumana R Sudhakaran; Chuanfu Li; Nilanjana Maulik
Journal:  Diabetes       Date:  2009-09-30       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.